Williams Jones & Associates’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Williams Jones & Associates's BIIB Position: Q2 2019 in Review
Williams Jones & Associates reduced its Biogen (BIIB) stake by 43% in Q2 2019, selling an estimated $166K and leaving 937 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #353.
Williams Jones & Associates first reported a position in BIIB in Q4 2014 and has held it in 19 quarters since. The position peaked at $11.3M in Q2 2015. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.
- Williams Jones & Associates held 937 shares of Biogen worth $219K as of Q2 2019.
- Williams Jones & Associates sold 720 Biogen shares in Q2 2019, an estimated $166K.
- Biogen made up ﹤0.01% of Williams Jones & Associates's portfolio in Q2 2019, its #353 holding.
- Williams Jones & Associates first reported a position in Biogen in Q4 2014 and has held it in 19 quarters since.
- Williams Jones & Associates's Biogen position peaked at $11.3M in Q2 2015.
- 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.
Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.